These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31966070)

  • 1. TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC.
    Lou M; Gao Z; Zhu T; Mao X; Wang Y; Yuan K; Tong J
    Oncol Lett; 2020 Feb; 19(2):1400-1408. PubMed ID: 31966070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of TRIM59 in Non-small Cell Lung Cancer and Its Correlation with Prognosis].
    Tian H; Zhang D; Xu R; Qin Y; Lan Y; Jiao W; Han Y
    Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):21-28. PubMed ID: 31948534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysis.
    Hao L; Du B; Xi X
    Oncol Lett; 2017 Aug; 14(2):2153-2164. PubMed ID: 28789440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of SLC6A10P contributes to poor prognosis in lung adenocarcinoma.
    Yuan K; Gao ZJ; Yuan WD; Yuan JQ; Wang Y
    Int J Clin Exp Pathol; 2018; 11(2):720-726. PubMed ID: 31938158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM59: A potential diagnostic and prognostic biomarker in human tumors.
    Jin Z; Liu L; Yu Y; Li D; Zhu X; Yan D; Zhu Z
    PLoS One; 2021; 16(9):e0257445. PubMed ID: 34534244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tripartite motif-containing 15 overexpression in non-small cell lung cancer is associated with poor patient prognoses.
    Han X; Huang C; Qu X; Liu S; Yang X; Wang Y; Bie F; Liu Q; Du J
    J Cancer; 2019; 10(4):843-852. PubMed ID: 30854090
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential value of tripartite motif-containing 59 as a biomarker for predicting the prognosis of patients with lung cancer: A protocol for systematic review and meta-analysis.
    Guo J; Min K; Deng L
    Medicine (Baltimore); 2021 Aug; 100(32):e26868. PubMed ID: 34397900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM59 regulates autophagy through modulating both the transcription and the ubiquitination of BECN1.
    Han T; Guo M; Gan M; Yu B; Tian X; Wang JB
    Autophagy; 2018; 14(12):2035-2048. PubMed ID: 30231667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of TRIM59 for cancer patient survival: A systematic review and meta-analysis.
    Wang M; Chao C; Luo G; Wang B; Zhan X; Di D; Qian Y; Zhang X
    Medicine (Baltimore); 2019 Nov; 98(48):e18024. PubMed ID: 31770215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression.
    Wang Y; Zhou Z; Wang X; Zhang X; Chen Y; Bai J; Di W
    Int J Biol Sci; 2018; 14(14):2073-2082. PubMed ID: 30585270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53.
    Liu R; Li H; Xu Y; Li X; Guo X; Shi J; Cui Y; Wang Z; Liu J
    Oncol Lett; 2021 Jan; 21(1):6. PubMed ID: 33240412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of tripartite motif 59 and its diagnostic utility in benign bowel diseases and colorectal cancer.
    Dahpy MA; Salama RHM; Kamal AA; El-Deek HE; AbdelMotaleb AA; Abd-El-Rehim AS; Hassan EA; Alsanory AA; Saad MM; Ali M
    J Biochem Mol Toxicol; 2022 Jul; 36(7):e23065. PubMed ID: 35377964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.
    Schlensog M; Magnus L; Heide T; Eschenbruch J; Steib F; Tator M; Kloten V; Rose M; Noetzel E; Gaisa NT; Knüchel R; Dahl E
    Epigenetics; 2018; 13(3):214-227. PubMed ID: 27623992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins.
    Zhan W; Han T; Zhang C; Xie C; Gan M; Deng K; Fu M; Wang JB
    PLoS One; 2015; 10(11):e0142596. PubMed ID: 26599082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-β/Smad2/3 signaling pathway in bladder cancer cells.
    Chen W; Zhao K; Miao C; Xu A; Zhang J; Zhu J; Su S; Wang Z
    Onco Targets Ther; 2017; 10():1503-1512. PubMed ID: 28331343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tripartite Motif-Containing Protein 59 (TRIM59) Promotes Epithelial Ovarian Cancer Progression via the Focal Adhesion Kinase(FAK)/AKT/Matrix Metalloproteinase (MMP) Pathway.
    Zhang P; Zhang H; Wang Y; Zhang P; Qi Y
    Med Sci Monit; 2019 May; 25():3366-3373. PubMed ID: 31062766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway.
    Sun Y; Ji B; Feng Y; Zhang Y; Ji D; Zhu C; Wang S; Zhang C; Zhang D; Sun Y
    Oncol Rep; 2017 Jul; 38(1):43-52. PubMed ID: 28534983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skp2 expression has different clinicopathological and prognostic implications in lung adenocarcinoma and squamous cell carcinoma.
    Zhong K; Yang F; Han Q; Chen J; Wang J
    Oncol Lett; 2018 Sep; 16(3):2873-2880. PubMed ID: 30127874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
    Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
    Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.